Response Genetics (RGDX) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents
Accounts receivable	6.06M
Prepaid expenses and other current assets	962.06K
Total current assets	8.76M
Property and equipment, net	1.27M
Total assets	10.78M
Accounts payable	1.71M
Accrued expenses	418.26K
Accrued royalties	963.68K
Accrued payroll and related liabilities	1.53M
Deferred revenue
Total current liabilities	4.88M
Deferred revenue, net of current portion
Total liabilities	15.72M
Commitments and contingencies (Note 5)	0
Common stock classified outside of stockholders' equity (deficit)
Common stock, $0.01 par value; 50,000,000 shares authorized; 18,357,406 and 19,537,232 shares issued and outstanding at December 31, 2010 and June 30, 2011, respectively	388.01K
Additional paid-in capital	77.98M
Accumulated deficit	-83.01M
Accumulated other comprehensive loss	-287.9K
Total stockholders' equity (deficit)	-4.94M
Total liabilities and stockholders' equity (deficit)	10.78M

Entities mentioned with RGDX

View All Entities